CD56 Expression Is an Important Prognostic Factor in Multiple Myeloma Even with Bortezomib Induction. - Skerget M; Skopec B; Zadnik V; Zontar D; Podgornik H; Rebersek K; Furlan T; Cernelc P (Acta haematologica, 2018)